Pyrolate

Therapeutic Group

Indication Dosage

Glycopyrrolate is a medication primarily prescribed to manage excessive drooling or saliva production in individuals with certain medical conditions, such as cerebral palsy and Parkinson's disease. It is also used to alleviate symptoms associated with gastrointestinal disorders like irritable bowel syndrome and peptic ulcers, by reducing stomach acid secretion. 

Control Of Upper Airway Secretions: 

Intra-operative: 

By IV Inj: 

• Adult: 0.1 Mg Repeated As Needed At 2-3 Mins Intervals. 
• Children: Neonate: 10 Mcg/kg, Repeated If Necessary; 1 Month-18 Yr: 4-8 Mcg/kg, Max 200 Mcg, Repeated If Necessary. 

Excessive Secretions Of The Respiratory Tract Preoperative: 

By IM Or IV Inj: 

• Adult: 4.4 Mcg/kg 30-60 Min Before Procedure 
• Children: Neonate: 5 Mcg/kg; 1 Month-12 Yr: 4-8 Mcg/kg, Max 200 Mcg; 12-18 Yr: 200-400 Mcg Or 4-5 Mcg/kg, Max 400 Mcg. 

Reverse Neuromuscular Blockade: 

By IV Inj: 

• Adult: 0.2 Mg For Each 1 Mg Of Neostigmine Or 5 Mg Of Pyridostigmine Administered Or 5-15 Mcg/kg Glycopyrrolate With 25-70 Mcg/kg Of Neostigmine Or 0.1-0.3 Mg/kg Of Pyridostigmine (agents Usually Administered Simultaneously, But Glycopyrrolate May Be Administered First If Bradycardia Is Present). 
• Children: Neonate, 10 Mcg/kg; 1 Month-12 Yr: 10 Mcg/kg, Max 500 Mcg; 12-18 Yr: 200 Mcg Per 1 Mg Of Neostigmine, Or 10-15 Mcg/kg. 

Adjunct In Treatment Of Peptic Ulcer: 

By IM Or IV Inj: 

• Adult: 0.1-0.2 Mg 3-4 Times A Day. 

Oral: 

• Adult: 1-2 Mg 2-3 Times Daily.

Content

Pregnancy

Caution Advised

Stability

Contra Indications

Precautions

Lactation

Side Effects